What are the main symptoms of diabetic retinopathy in patients with type 1 diabetes after five years of disease and in patients with type 2 diabetes at diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Main Symptoms of Diabetic Retinopathy

Diabetic retinopathy is typically asymptomatic in its early and moderate stages, which is precisely why systematic screening is critical—patients often have no visual complaints until irreversible damage has occurred. 1

Early Disease (Mild to Moderate Nonproliferative Retinopathy)

  • Patients experience no symptoms whatsoever in the early stages of diabetic retinopathy, despite the presence of microaneurysms, dot-and-blot hemorrhages, and hard exudates on examination. 2, 3

  • Visual field testing in eyes with mild disease (ETDRS levels 10-35) shows no evidence of field loss, with mean deviation values remaining normal in 96% of cases. 4

  • This asymptomatic period can persist for years, particularly in type 1 diabetes where retinopathy typically requires at least 5 years of hyperglycemia to develop. 1

Advanced Disease (Severe Nonproliferative and Proliferative Retinopathy)

When symptoms finally appear, they indicate advanced disease:

  • Vision loss or blurred vision occurs from vascular leakage causing macular edema or from retinal ischemia. 2, 3

  • Floaters or dark spots result from vitreous hemorrhage when new abnormal blood vessels rupture. 2, 3

  • Visual field defects become evident in moderate to severe disease (ETDRS levels 43-65), with 44% of eyes showing significantly reduced mean deviation values and 6.5% of tested points demonstrating reproducible sensitivity loss. 4

  • Sudden vision loss can occur from tractional retinal detachment or dense vitreous hemorrhage. 3

Diabetic Macular Edema

  • Central vision impairment develops when fluid accumulates in the macula, which can occur at any stage of retinopathy. 3

  • This is the most common cause of legal blindness in non-insulin dependent diabetics and frequently produces central vision loss. 5

  • Macular edema threatens visual acuity and requires prompt ophthalmologic referral regardless of the stage of background retinopathy. 1

Critical Clinical Pitfall

The absence of symptoms does not indicate absence of disease. Nearly all diabetic patients will develop some degree of retinopathy after 20 years of diabetes, and 50% of those with type 1 diabetes will have proliferative retinopathy after 15 years—most progressing silently until vision-threatening complications arise. 5

This is why the American Diabetes Association mandates screening within 5 years of type 1 diabetes diagnosis and immediately at type 2 diabetes diagnosis, regardless of whether patients report any visual complaints. 1

Special Consideration: Rapid Glycemic Control

  • Paradoxical worsening of retinopathy can occur as an early symptom when intensive glycemic management is rapidly implemented, particularly with GLP-1 receptor agonists. 1

  • This represents initial worsening before long-term benefit and requires more frequent ophthalmologic monitoring. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Screening for and managing diabetic retinopathy: current approaches.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007

Research

Diabetic retinopathy: Early diagnosis and effective treatment.

Deutsches Arzteblatt international, 2010

Research

Diabetic retinopathy: current concepts of evaluation and treatment.

Clinics in endocrinology and metabolism, 1986

Related Questions

What are the findings associated with diabetic retinopathy in a patient with a history of diabetes and poorly controlled blood sugar levels?
What are the preoperative management recommendations for a patient with diabetic retinopathy, impaired renal function, and a benign uterine myoma (uterine fibroid) scheduled for operation?
When should a diabetic (DM) patient be referred to an ophthalmologist for screening?
What are the clinical features of diabetic retinopathy?
What is diabetic retinopathy, its natural history, epidemiology, pathophysiology, classification, clinical manifestations, diagnosis, prevention, and treatment options?
In an elderly woman on buspirone 5 mg twice daily and sertraline 75 mg daily with sleep‑maintenance insomnia (falls asleep easily but awakens after a few hours), what is the most appropriate pharmacologic treatment?
A 30‑year‑old adult male diagnosed 10 years ago with panic attacks and death phobia was treated for 2 years with low‑dose paroxetine (25 mg), low‑dose amisulpride (50 mg) and as‑needed etizolam (0.5 mg), then discontinued. Five years after stopping, he now reports frequent anger outbursts, loss of pleasure, easy irritability, excessive masturbation, persistent over‑thinking of minor issues and harsh speech. What is the most appropriate next step in his management?
What is the safest, most affordable treatment for an elderly woman with sleep‑maintenance insomnia who is already taking buspirone 5 mg twice daily and sertraline 75 mg daily, given that her insurance will not cover doxepin, ramelteon, or eszopiclone (Lunesta)?
How should diarrhea be evaluated and managed in a patient receiving dialysis?
Are there peer‑reviewed articles on estrogen‑related changes of the labia majora and labia minora in post‑menopausal women?
In a healthy reproductive‑age woman with night sweats confined to the luteal phase (the 1‑2 weeks after ovulation), what is the likely cause and what are the appropriate evaluation and management steps?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.